The "Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course (Feb 11th - Feb 12th, 2026)" training has been added to ResearchAndMarkets.com's offering.

Taiwanese drugmaker ScinoPharm (TWSE: 1789) has secured approval from the US Food and Drug Administration for its glatiramer ...

The Danish American who doubted Covid shots is meant to lead drug regulation – but has focused on vaccines ...

ScinoPharm Taiwan (TWSE: 1789) today announced a landmark achievement in the global pharmaceutical landscape, securing U.S. Food and Drug Administration (FDA) approval for Glatiramer Acetate Injection ...

Hyderabad based HRV Pharma, India’s ‘first virtual pharmaceutical company’, started off as a B2B match maker between Indian ...

Pharmaceutical Intermediates Market OverviewThe global pharmaceutical intermediates market is witnessing steady expansion as pharmaceutical manufacturing scales worldwide. Valued at approximately USD ...

The performance metrics speak volumes. The iShares Biotechnology ETF (NASDAQ: IBB) has climbed 29.51% year to date through December 29, while the State Street SPDR S&P Biotech ETF (NASDAQ: XBI) has ...

Despite limited uptake, weight-loss drugs have topped drug sales in India by value — marking a shift in how people perceive ...

The recent wave of pharmaceutical tragedies in Sri Lanka, as well as some others that have occurred regularly in the past, ...

ScinoPharm Taiwan (TWSE: 1789) today announced a landmark achievement in the global pharmaceutical landscape, securing U.S. Food ...

The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.

Novo Nordisk's long game on weight loss drugs sparks hope in science, but the Street is impatient Novo Nordisk has had a ...